After finally deciding that increased competition in the drug retail sector is worth reducing government control over distribution channels, the mail-order trade in pharmaceuticals in Norway looks set to be legalized in 2009. Although the use of the Internet has previously been permitted for placing orders for medicines, the authorities refused to allow the use of the postal service for the delivery of products, forcing on-line retailers to use more expensive courier services.
Initially, the plan is to allow over-the-counter agents to be distributed through the mail, and the necessary regulatory changes will likely take effect in the summer of this year, a spokesman for the Norwegian Medicines Agency (NoMA) said. If this is successful, the NoMA anticipates extending deregulation to prescription drugs.
A spokesman for the Norwegian Association of Pharmaceutical Manufacturers (LMI) told the Marketletter that it is monitoring changes to the retail distribution sector very closely. The lifting of restrictions to allow properly-licensed pharmacies to operate more efficiently, is a development that is welcomed by drugmakers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze